Peptide Therapy — What It Is, What It Isn't, and Who It's Actually For — Dr. Jonas LaForge
Peptide therapy has moved from the fringes of integrative medicine into mainstream longevity conversations. Here is a clear, clinically grounded look at what peptides actually do, where they fit, and who they are genuinely for.
Peptide therapy has moved from the fringes of integrative medicine into mainstream longevity conversations remarkably quickly.
With that speed has come a significant amount of noise — overclaiming from some corners, reflexive dismissal from others, and a genuine shortage of clear, clinically grounded explanation for people who are trying to make an informed decision.
So let me provide that.
What Peptides Actually Are
Peptides are short chains of amino acids — the same building blocks that make up proteins. The difference is their length and specificity. Where proteins are large, complex molecules, peptides are smaller, more targeted, and capable of acting as precise biological signaling agents.
Your body already produces and uses peptides constantly. Insulin is a peptide. So is oxytocin. So are the growth hormone releasing hormones that govern your body's natural regenerative cycles.
Therapeutic peptides work by either mimicking, supporting, or amplifying these existing biological signals. They are not introducing a foreign substance into your physiology. They are communicating with systems that already exist — in the language those systems already speak.
What Peptide Therapy Is Not
It is not a shortcut. It is not a substitute for foundational health architecture. And it is not appropriate for every person at every stage of their health journey.
Peptide therapy deployed into a system burdened by chronic inflammation, poor sleep architecture, nutritional deficiency, and unaddressed metabolic dysfunction will produce suboptimal results at best. At worst, it will amplify existing imbalances.
The accelerant analogy applies here: pour the right fuel into a well-maintained engine, and performance improves. Pour it into a compromised system, and you accelerate the degradation.
The foundation has to be assessed first.
The Clinical Applications Worth Understanding
Growth Hormone Secretagogues — peptides such as Sermorelin, Ipamorelin, and CJC-1295 that stimulate the pituitary gland to produce and release growth hormone naturally, rather than introducing exogenous growth hormone directly. Applications include improved body composition, enhanced recovery, better sleep architecture, and cellular repair support.
BPC-157 — a body protection compound with significant evidence in tissue repair, gut healing, and neurological support. Particularly relevant for individuals with gut permeability issues, inflammatory conditions, or injury recovery requirements.
Thymosin Alpha-1 — an immune-modulating peptide with applications in immune system optimization, particularly relevant in the context of chronic immune activation, post-viral syndromes, and autoimmune presentations.
PT-141 — a melanocortin receptor agonist with applications in sexual health and libido, addressing the neurological rather than vascular component of sexual dysfunction.
Who Peptide Therapy Is Actually For
Peptide therapy is most appropriate and most effective for individuals who have completed a comprehensive health assessment and identified specific biological gaps that peptide protocols are well-positioned to address. Who have addressed foundational lifestyle architecture — sleep quality, nutritional status, metabolic health, inflammatory burden — to the degree that the system can actually respond to the intervention. Who have a clinical relationship with a practitioner who understands both the mechanisms and the monitoring requirements involved.
It is less appropriate — and potentially counterproductive — for individuals seeking a biological shortcut before doing the foundational work.
The Bigger Picture
The question worth asking before pursuing any advanced longevity intervention is not "does this work?" — the evidence base for many of these tools is genuinely compelling.
The question is: Is my biological system in a position to respond to this optimally? And do I have a clear picture of what I am trying to address and why?
If the answer to both of those questions is yes — the conversation about advanced tools becomes much more interesting.
We begin every Concierge Longevity engagement with that assessment — before any protocol is designed.